Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer Guideline

  • Publication

    Online – April 2017

    This guideline addresses four areas related to the treatment of muscle-invasive bladder cancer that has not metastasized. It first discusses initial patient evaluation and counseling and then offers recommendations on treatment. The therapies considered included neoadjuvant chemotherapy, radical cystectomy, pelvic lymphadectomy and bladder preserving approaches. The guideline also looks at patient surveillance, follow-up and survivorship and the role of variant histology for management of urothelial carcinoma.

    Read full guideline

    Read the executive summary

    Quick Reference

    • Initial patient evaluation and counseling
    • Patient surveillance and follow up
    • Bladder preservation

    Muscle Invasive Bladder Cancer Algorithum

    Author Society
    American Society for Radiation Oncology
    American Urological Association
    American Society of Clinical Oncology
    Society of Urologic Oncology

    Previous version

  • Disclaimer

    ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.